Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Neumora Therapeutics Inc (NASDAQ: NMRA) closed the day trading at $2.59 down -3.72% from the previous closing price of $2.69. In other words, the price has decreased by -$3.72 from its previous closing price. On the day, 1.39 million shares were traded. NMRA stock price reached its highest trading level at $2.7 during the session, while it also had its lowest trading level at $2.56.
Ratios:
For a better understanding of NMRA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.54 and its Current Ratio is at 10.54. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.11.
BofA Securities Downgraded its Buy to Underperform on April 02, 2025, while the target price for the stock was maintained at $1.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’25 when Henry Gosebruch bought 15,000 shares for $1.43 per share.
BERNS PAUL L sold 13,871 shares of NMRA for $23,468 on Feb 18 ’25. The insider now owns 7,405,004 shares after completing the transaction at $1.69 per share. On Feb 18 ’25, another insider, Milligan Michael Lee, who serves as the insider of the company, sold 1,978 shares for $1.69 each. As a result, the insider received 3,351 and left with 22,470 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMRA now has a Market Capitalization of 419438624 and an Enterprise Value of 221811648.
Stock Price History:
The Beta on a monthly basis for NMRA is 3.08, which has changed by -0.7796888 over the last 52 weeks, in comparison to a change of 0.18258524 over the same period for the S&P500. Over the past 52 weeks, NMRA has reached a high of $14.09, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 44.05%, while the 200-Day Moving Average is calculated to be 85.77%.
Shares Statistics:
Over the past 3-months, NMRA traded about 1.14M shares per day on average, while over the past 10 days, NMRA traded about 3915820 shares per day. A total of 161.95M shares are outstanding, with a floating share count of 54.24M. Insiders hold about 66.51% of the company’s shares, while institutions hold 22.94% stake in the company. Shares short for NMRA as of 1760486400 were 6788203 with a Short Ratio of 5.96, compared to 1757894400 on 6417308. Therefore, it implies a Short% of Shares Outstanding of 6788203 and a Short% of Float of 11.560000500000001.
Earnings Estimates
At present, 6.0 analysts are actively evaluating the performance of Neumora Therapeutics Inc (NMRA) in the stock market.The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.28 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.32 and -$1.54 for the fiscal current year, implying an average EPS of -$1.42. EPS for the following year is -$1.01, with 6.0 analysts recommending between -$0.58 and -$1.62.
